Learn more about whether AstraZeneca PLC or Corcept Therapeutics Incorporated is a better investment based on AAII's A+ ...

Learn more about whether AstraZeneca PLC or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

AstraZeneca Plc’s experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes ...

AstraZeneca Plc‘s win over shareholders who challenged its $3 billion sale of biotech firm Viela Bio Inc. was affirmed ...

We recently compiled a list of the 12 Best ADR Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to ...

AstraZeneca's new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.

According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $89.75. AZN opened at $73.79 on Friday. AstraZeneca PLC has a twelve ...

AstraZeneca PLC AZN shares slid 1.34% to £114.52 Monday, on what proved to be an all-around rough trading session for the ...

Xponance Inc. raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 6.9% during the fourth quarter, ...

AstraZeneca PLC closed 14.73% below its 52-week high of £133.88, which the company achieved on September 3rd.

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and ...